The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 04, 2025
Filed:
May. 09, 2023
Applicant:
Intra-cellular Therapies, Inc., New York, NY (US);
Inventors:
Peng Li, New Milford, NJ (US);
Qiang Zhang, Plainsboro, NJ (US);
Robert Davis, San Diego, CA (US);
Lawrence P. Wennogle, Steamboat Springs, CO (US);
Assignee:
INTRA-CELLULAR THERAPIES, INC., Bedminster, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/437 (2006.01); A61K 9/48 (2006.01); A61K 9/50 (2006.01); A61K 31/4985 (2006.01); A61K 47/34 (2017.01); A61K 47/38 (2006.01); C07D 471/14 (2006.01); C07D 471/16 (2006.01); C07D 471/22 (2006.01);
U.S. Cl.
CPC ...
C07D 471/16 (2013.01); A61K 9/4825 (2013.01); A61K 9/4891 (2013.01); A61K 9/5031 (2013.01); A61K 31/4985 (2013.01); A61K 47/34 (2013.01); A61K 47/38 (2013.01); C07D 471/14 (2013.01);
Abstract
The invention relates to pharmaceutical compositions comprising compounds of Formula Q: wherein W is —N(CH)—, and Y is —CH(OH)—, in free base or pharmaceutically acceptable salt form, and methods of use in the treatment of diseases involving 5-HTreceptor, serotonin transporter (SERT) pathway and/or the dopamine Dreceptor pathway, and methods of treating conditions of the central nervous system therewith.